News
NEOG
20.04
+0.80%
0.16
Bausch + Lomb: Still A Favorable Risk-To-Reward Prospect
Seeking Alpha · 3d ago
KPTI, VRNA and SGH are among after hour movers
Seeking Alpha · 01/20 21:58
Around $10M Bet On This Biotechnology Stock? Check Out These 3 Stocks Insiders Are Buying
Benzinga · 01/19 12:17
3M Company: 2023, Year Of Legal Focus
Seeking Alpha · 01/10 00:15
BRIEF-Neogen Announces Second-Quarter 2023 Results
Reuters · 01/05 12:09
Neogen Reports Lower Fiscal Q2 Adjusted Earnings, Revenue Climbs
Neogen Reports Lower Fiscal Q2 Adjusted Earnings, Revenue Climbs
MT Newswires · 01/05 07:23
-- Earnings Flash (NEOG) NEOGEN CORPORATION Posts Q2 Revenue $230M, vs. Street Est of $228.3M
-- Earnings Flash (NEOG) NEOGEN CORPORATION Posts Q2 Revenue $230M, vs. Street Est of $228.3M
MT Newswires · 01/05 07:15
-- Earnings Flash (NEOG) NEOGEN CORPORATION Reports Q2 EPS $0.15, vs. Street Est of $0.14
-- Earnings Flash (NEOG) NEOGEN CORPORATION Reports Q2 EPS $0.15, vs. Street Est of $0.14
MT Newswires · 01/05 07:07
Neogen Earnings Preview
Benzinga · 01/04 15:00
Neogen: Thinning ROIC, Economic Profit, Downside Risks Looking Ahead
Seekingalpha · 12/28/2022 23:53
BRIEF-Aoac Certifies Neogen's Reveal 3-D For Gluten
Reuters · 12/20/2022 13:51
AOAC Certifies Neogen's Reveal 3-D For Gluten Test
Benzinga · 12/20/2022 13:46
Neogen Receives AOAC Certification for Reveal 3-D for Gluten Test
Neogen Receives AOAC Certification for Reveal 3-D for Gluten Test
MT Newswires · 12/20/2022 11:03
--Piper Sandler Adjusts Price Target on Neogen to $17 From $14, Maintains Neutral Rating
--Piper Sandler Adjusts Price Target on Neogen to $17 From $14, Maintains Neutral Rating
MT Newswires · 12/15/2022 11:57
Piper Sandler Maintains Neutral on Neogen, Raises Price Target to $17
Benzinga · 12/15/2022 11:13
Neogen (NEOG) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
Neogen (NEOG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks · 12/13/2022 15:00
Neogen® to Participate in the Piper Sandler 34th Annual Healthcare Conference
Neogen Corporation (NASDAQ: NEOG) announced today that the Company will participate in the Piper Sandler 34th Annual Healthcare Conference in New York City on Wednesday, November 30, 2022.
PR Newswire · 11/23/2022 13:45
--William Blair Upgrades Neogen to Outperform From Market Perform
--William Blair Upgrades Neogen to Outperform From Market Perform
MT Newswires · 11/22/2022 08:07
Neogen® Releases New Dual-Detection Needle for Production Farmers
Neogen Corporation (NASDAQ: NEOG) announced today that it has released an upgraded version of its best-selling Ideal® D3™ detectable needles, designed to be six times more detectable than the conventional and stainless-steel needles.
PR Newswire · 11/15/2022 13:50
Neogen Launches Synergize Disinfectant In Europe, The Middle East, Africa
Benzinga · 11/15/2022 13:47
More
Webull provides a variety of real-time NEOG stock news. You can receive the latest news about Neogen Corp through multiple platforms. This information may help you make smarter investment decisions.
About NEOG
Neogen Corporation is engaged in developing, manufacturing and marketing a range of products and services dedicated to food and animal safety. The Company operates through two segments: Food Safety and Animal Safety. Its Food Safety segment is primarily engaged in the production and marketing of diagnostic test kits and complementary products marketed to food and feed producers and processors to detect dangerous and/or unintended substances in food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant byproducts, meat speciation, drug residues, pesticide residues and general sanitation concerns. Its Animal Safety segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodenticides, cleaners, disinfectants, insecticides and genomics testing services for the worldwide animal safety market.